Wellington Management Group’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-18,632
| Closed | -$1.99M | – | 2088 |
|
|
2025
Q3 | $1.99M | Sell |
18,632
-1,611,216
| -99% | -$168M | ﹤0.01% | 1632 |
|
|
2025
Q2 | $154M | Sell |
1,629,848
-501,654
| -24% | -$37.1M | 0.03% | 420 |
|
|
2025
Q1 | $135M | Sell |
2,131,502
-893,739
| -30% | -$53.5M | 0.03% | 442 |
|
|
2024
Q4 | $140M | Buy |
3,025,241
+1,146,609
| +61% | +$43M | 0.03% | 454 |
|
|
2024
Q3 | $54M | Buy |
1,878,632
+307,272
| +20% | +$7.56M | 0.01% | 677 |
|
|
2024
Q2 | $22.7M | Sell |
1,571,360
-2,338,106
| -60% | -$34.1M | ﹤0.01% | 913 |
|
|
2024
Q1 | $62.9M | Buy |
3,909,466
+125,472
| +3% | +$2.17M | 0.01% | 645 |
|
|
2023
Q4 | $75.2M | Sell |
3,783,994
-683,577
| -15% | -$10.1M | 0.01% | 621 |
|
|
2023
Q3 | $72.8M | Buy |
4,467,571
+164,268
| +4% | +$3.16M | 0.01% | 610 |
|
|
2023
Q2 | $91M | Buy |
4,303,303
+1,011,830
| +31% | +$21.6M | 0.02% | 572 |
|
|
2023
Q1 | $66.1M | Sell |
3,291,473
-54,897
| -2% | -$1.19M | 0.01% | 630 |
|
|
2022
Q4 | $87.4M | Sell |
3,346,370
-830,906
| -20% | -$11.1M | 0.02% | 553 |
|
|
2022
Q3 | $42.7M | Buy |
4,177,276
+349,127
| +9% | +$2.94M | 0.01% | 709 |
|
|
2022
Q2 | $16M | Buy |
3,828,149
+49,364
| +1% | +$211K | ﹤0.01% | 1004 |
|
|
2022
Q1 | $18.9M | Sell |
3,778,785
-1,053,203
| -22% | -$6.13M | ﹤0.01% | 1033 |
|
|
2021
Q4 | $32.5M | Buy |
4,831,988
+537,950
| +13% | +$2.75M | 0.01% | 962 |
|
|
2021
Q3 | $23.5M | Buy |
4,294,038
+382,198
| +10% | +$2.22M | ﹤0.01% | 1049 |
|
|
2021
Q2 | $25.6M | Buy |
3,911,840
+113,699
| +3% | +$788K | ﹤0.01% | 1033 |
|
|
2021
Q1 | $31.8M | Buy |
3,798,141
+2,552,442
| +205% | +$21.2M | 0.01% | 946 |
|
|
2020
Q4 | $8.72M | Buy |
+1,245,699
| New | +$8.41M | ﹤0.01% | 1215 |
|
Other funds holding VRNA
Wellington Management Group's VRNA Position: Q4 2025 in Review
Wellington Management Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 18,632 shares — an estimated $1.99M sold.
Wellington Management Group first reported a position in VRNA in Q4 2020 and held it in 20 quarters. The position peaked at $154M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Wellington Management Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Wellington Management Group sold 18,632 Verona Pharma shares in Q4 2025, an estimated $1.99M.
- Wellington Management Group first reported a position in Verona Pharma in Q4 2020 and held it in 20 quarters.
- Wellington Management Group's Verona Pharma position peaked at $154M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.